Abstract Details

Title Multiple Sclerosis Patients Treated with IFNB-1b Express a Unique Isoform of the Oxidation Resistance Protein NCOA7

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 073

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Edward Croze, PhD	No disclosure on file
Volker A. Knappertz, MD (Lacum Neurology)	Dr. Knappertz has received personal compensation for serving as an employee of Noema Pharmaceuticals . Dr. Knappertz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Sutura Pharmaceutical . Dr. Knappertz has received intellectual property interests from a discovery or technology relating to health care.
Michael Volkert (UMASS Medical School)	No disclosure on file
Peter Aupperle	No disclosure on file

��ɫ��